Form 8-K - Current report:
SEC Accession No. 0001104659-25-051324
Filing Date
2025-05-21
Accepted
2025-05-21 08:31:52
Documents
13
Period of Report
2025-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515741d1_8k.htm   iXBRL 8-K 26276
2 EXHIBIT 99.1 tm2515741d1_ex99-1.htm EX-99.1 12564
  Complete submission text file 0001104659-25-051324.txt   206562

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20250520.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20250520_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20250520_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2515741d1_8k_htm.xml XML 3644
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 25970967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)